SharePoint
Contact Home

Virtual Program

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Program


Target Audience
The conference is designed for nurses and other health care professionals interested in recent developments in the field of pediatric endocrinology nursing, including pediatric diabetes.
Program Goals
It is PENS’ goal to promote high quality endocrinology nursing practice through this educational offering. Conference participants receive the latest information in basic to advanced practice, experience and research as demonstrated by pediatric endocrinologists and pediatric endocrinology nurses.
Program Objectives​
  • Develop new skills to improve educational and patient outcomes
  • Provide educational opportunities in pediatric endocrinology for nurses and others with expertise in the area
  • Promote the pursuit of nursing practice and research through a research presentation and poster session
  • Provide educational opportunities in the management and treatment of selected endocrine disorders
  • Provide direction for understanding health care changes
PENS Conference Planning Committee
Leigh Pughe, RN, MS, CPNP, Chair
Christin Morell, RN, BSN, Vice Chair
Sheri L. Luke, MSN, FNP-C
Josie Hong, BSN, RN
Amanda Patterson, BSN, RN
Jennifer Anisko, CRNP, CDCES
Catherine Flynn, RN, MSN, APRN, CDCES, Board Liaison
Accreditation
This activity will be submitted to the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91).
Networking
The opportunity to develop and continue relationships with your colleagues through networking is one of the key benefits of participating in the PENS Conference. Networking offers many tangible benefits to conference participants, including, but not limited to, validating your experience in providing nursing care and developing a better understanding of your practice and your role in care delivery by learning from others who are dealing with similar circumstances, solving the same problems, and confronting the same issues. The Conference Planning Committee is working on ways to make this virtual experience as equally as interactive as an in-person event to learn more about national issues and trends.
Po​sters
PENS is providing a venue for conference attendees to view and discuss participants’ poster presentations. Visit with the poster presenters and learn about current research that will affect your clinical practice during the live sessions!

​​Wednesday, April 21, 2021

Time (ALL TIMES EASTERN) ​Presentation/Event Prese​nter(s)
12:00 p.m. - 12:15 p.​m.
Welcome & Opening Remarks
Catherine Flynn, RN, MSN, APRN, CDCES
​12:15 p.m. - 1:15 p.​m.
1.0 Contact Hour*
Keynote Address
Laurie Cameron is the author of The Mindful Day: Practical Ways to Find Focus, Calm and Joy, National Geographic, 2018, and is known for her warmth, energy and insight sharing the science of human flourishing and development. Laurie integrates emotional intelligence, positive psychology, mindfulness, compassion and neuroscience into everyday language for modern work and life.

​​Laurie J. Cameron



1:15 p.m. - 2:15 p.​m.
1.0 Contact Hour*
Managing Diabetes During the COVID-19 Pandemic: A Story of Change and Discovery in a Pediatric Diabetes Center
When the pandemic hit the Philadelphia area in March 2020, it turned our world upside-down.  Every process that we had in our center had to change, and serving our patients and families became very complicated. With a flurry of ingenuity and forward thinking, the diabetes team rose to the occasion and developed new tools and procedures to make sure that every family had what they needed to manage diabetes well during the pandemic.  The changes that we made have led to some exciting new innovations in diabetes care that we hope to bring with us into the future. PENS members have had to make many changes in practice as well during the COVID-19 pandemic, and together we can share some of the best practices that we have developed to meet the challenges that we have faced as pediatric endocrinology nurses.
Melissa Andrews Rearson, MSN, CRNP
2:15 p.m. - 2:45 p.m. ​​Break/Visit Exhibits

2:45 p.m. - 3:45 p.m.
1.0 Contact Hour*
​Navigating Evaluation and Treatment of Endocrinopathies in Pediatric Cancer Survivors
Caring for the endocrine needs of a cancer survivor requires additional understanding and consideration.  We will review common endocrinopathies seen in these patients, define treatment-related risks, and explore special considerations for treatment unique to the population. Endocrine late-effects are common in cancer survivors, but recommended surveillence and considerations for treatment are not well understood in the general endocrine community. How to access the Children's Oncology Group long-term follow-up guidelines and apply them to a general practice will be covered, and special considerations (i.e., use of GH in these patients) will be discussed in more depth. If you care for cancer survivors in your practice, following the most up-to-date guidelines, based on consensus and up-to-date evidence, is imperitive.  It is not always enough to rely on previous endocrine experience, as there are a number of unique factors at play to ensure these patients are not exposed to undue risk.                                                 
Megan Pruett, MSN, CPNP
3:45 p.m. - 4:45 p.m.
1.0 Contact Hour*
Racial/Ethnic Disparities in Youth Attending Diabetes Camps

Data for a large national network of diabetes camps showed that minority youth are less likely to participate in diabetes camp programming.  Learn about the existing disparities in diabetes camp attendance as compared to the national population of diabetes youth, and understand the potential barriers that exist for youth in attending diabetes camps.  We must work together to create processes to mitigate these barriers. 

Risa Wolf, MD
4:45 p.m. - 6:45 p.m.
6:45 p.m. - 7:45 p.m.

Product Theaters 

Welcome Reception 

Thursday, April 22, 2021
Time (ALL TIMES EASTERN) Presentation​/Event Presenter(s)
12:30 p.m. - 1:30 p.m.
Novo Nordisk Symposium - Short Stature Case Study: Noonan Syndrome
This presentation provides a brief overview of Noonan syndrome and a Noonan syndrome patient case study. This presentation also reviews treatment for patients with Noonan syndrome.
Alicia Romano, MD
1:30 p.m. - 2:00 p.m.
Visit Exhibits
2:00 p.m. - 3:15 p.m.
1.25 Contact Hour*
​Research Grant and Oral Abstract Presentations
Terri Lipman, PhD, CRNP, FAAN; Jennifer Morone, PhD, MA-ATR, RN; Margaret (Meg) Keil, PhD, CRNP, Louise Fleming, PhD, RN; Erika McCann, RN, CPN, BSN, BS, MS
​3:15 p.m. - 4:15 p.m.
1.0 Contact Hour*
CONCURRENT SESSION 1
1A Diabetes Case Studies

1A1 Do We Have to Use Insulin? Treatment Options for a Case of MODY5

1A2 Managing the Treatment of a Patient with Diabetes Mellitus and Growth Hormone Deficiency 



Seema Meighan, NP, MPH


Maureen Dever, MSN, CRNP, PPCNP-BC, CDCES

1B CAH Treatment and Transitioning to Adult Care
Ashwini Mallappa, MD

1C Endocrinology 101: Back to Basics Educational Program for Nursing and Ancillary Staff
Have you noticed a drift in knowledge as it relates to endocrine nursing practice? This presentation will address the journey that two endocrine staff nurses embarked on to address the gaps in caring for endocrine patients, especially among newly hired nursing and ancillary staff. This presentation will outline the content of and rationale behind the bedside nurse-led educational program, the interactive educational strategies and evaluation methods, and the positive quantitative and qualitative outcomes.  
​Alexis Morris, BSN, RN; Sara Rasmussen, BSN, RN, CPN
4:15 p.m. - 4:30 p.m.
Break/Visit Exhibits
4:30 p.m. - 5:30 p.m.
1.0 Contact Hour*


Landscape of Current Therapies for Central Precocious Puberty (CPP)  By the end of the presentation, Health Care Professionals (HCPs) will be able to recognize benefits and risks associated with existing and newly added treatments in the CPP treatment landscape and choose an appropriate therapy for CPP patients. There is, to our knowledge, no published review of CPP treatments that incorporates the latest approved therapies and provides details on the benefits and risks of the most widely used therapies in the context of the overall CPP treatment. Participants will:   
  • Develop understanding of how to better select appropriate therapy for CPP patients based on the benefits and risks of treatments that are available in CPP treatment landscape.   
  • Recognize factors that impact CPP patients’ experiences throughout the whole course of treatment.       
Keisha Bird, ARNP, NP



5:30 p.m. - 6:30 p.m.
1.0 Contact Hour*
Concurrent Session 2
2A Diabetes 101: Guidelines for Treatment
Diabetes is an autoimmune process. There are many changes to care with the technology improving insulin delivery and self care management. Core components of care will be reviewed, along with helpful technology.  Case studies will be used to explore developmental stage impact on cares.  We will also explore complications of care: high and low blood sugars, diabetes distress, possible impact on growth, depression, along with site care.    
Shari Liesch, MSN, APNP

2B Optimizing the Use of Continuous Glucose Monitoring in Children with Insulin Dependent Diabetes Mellitus
Diabetes technology has evolved rapidly in the past 5 years. This includes advances in continuous glucose monitoring, which has transformed the field of diabetes care and changed the lives of people affected by diabetes. In this presentation I will first review the function and use of currently available continuous glucose monitors. I will then discuss how to optimize the use of these devices. This will include reviewing solutions to common issues faced by families using these devices, such as alarm fatigue and skin irritation, and will also include a discussion of how to effectively interpret data from continuous glucose monitors. Importantly, this presentation will also address the disparities that exist in the uptake of CGM, as recent studies have shown that patients with lower parental education levels and family incomes are less likely to use CGM.   
Maggie West, RN, CDCES; Julia Tracey, MSN, CRNP, CDCES

2C Endocrine Case Studies
2C1 Swyer Syndrome, 46 XY Gonadal Dysgenesis

2C2 Tanner 3 Puberty in Baby:  Review of Differential Diagnoses, Endocrine Workup, and Interventions

Stephanie Marczal, MSN, PPCNP-BC, CNS
Kimberly Shoe, MSN, CPNP, CDCES
6:30 p.m. - 7:00 p.m.
Committee Meetings
7:00 p.m. - 9:00 p.m.
Evening Event
Friday, April 23, 2021
Time (ALL TIMES EASTERN)
Presentation​/Event
Presenter(s)
12:30 p.m. - 1:30 p.m.
1.0 Contact Hour*
Thyroid Radiology

John Dallas, MD
1:30 p.m. - 2:00 p.m.
0.5 Contact Hours*
Poster Session
Posters are available throughout the conference for review. During this session, poster presenters will be available to discuss research and answer questions. 




2:00 p.m. - 2:15 p.m.
Break/Visit Exhibits
2:15 p.m. - 3:15 p.m.
1.0 Contact Hour*
Concurrent Session 3

3A Impact of Central Precocious Puberty Treatments on Patients’ Quality of Life 
Health Care Professionals (HCPs) to be able to recognize the factors impacting quality of life and identify appropriate CPP treatment for patients. There is, to our knowledge, no published review of CPP treatment’s impact on patients’ quality of life. This presentation will educate HCPs how different treatment factors influence patients’ quality of life:  1. Recognize CPP treatment factors impacting patients’ quality of life that should be considered when choosing appropriate treatment   2. Recognize ways to increase CPP patients’ quality of life throughout the whole course of treatment.

Keisha Bird, ARNP, NP

3B Considerations for Fertility Preservation in Pediatric Oncology Patients
Fertility concerns are a huge worry among cancer patients and their families.  Options for fertility preservation do exist in these populations, but are not well known or understood outside the oncology world.  Endocrine providers are uniquely suited to aid in these conversations given our breadth of knowledge regarding hormones and puberty. Bringing concerns about adult fertility down to a pediatric level is an emerging practice - one ripe for development in smaller systems and private practices.  A unique and exciting role for endocrine nurses exists in this space.      Participants will learn to differentiate between standard of care and experimental options for fertility preservation, and how to overcome the unique challenges that present themselves in various situations.  
Megan Pruett, MSN, CPNP

3C Transitioning the Older Adolescent with Diabetes after an Acute Episode
People with diabetes encounter their most difficult time with self-management in the later teen and early adulthood years. Successful preparation for increased self-management required in an adult practice can avoid problems. The presenter will use an example of an adolescent with an acute diabetes problem to illustrate best practices for transition of care. The participants will increase their awareness of the importance of transition preparation in the pediatric setting and come away with useful resources.
Susan Renda, DNP, ANP-BC, CDCES, FANP, FAAN
3:15 p.m. - 4:15 p.m.
1.0 Contact Hour*



4:15 p.m. - 5
:15 p.m.
Pediatric Thyroid Cancer
The presenter will provide a general overview of pediatric thyroid cancer with several cases studies and discussion regarding emerging therapies.

Awards & Closing Remarks
Sarah J. Bottomley, DNP, APRN, CPNP
ON-DEMAND CONTENT
1.0 Contact Hour*The Story of the TODAY Study: Treatment Options for Type 2 Diabetes in Adolescents and Youth 
Any time children begin developing adult diseases it is an alarming and frightening circumstance. The TODAY study assembled the largest cohort of type 2 DM youth ever and spent many years getting to understand the trials and tribulations of this ever growing epidemic that continues to evolve in all corners of the world. This presenter will explain the entire process from recruitment, treatment modalities, retention, and prognosis of a population that is not typically studied. Working with a multi-disciplinary team from all corners of the country for many years provides a unique perspective in how to look not only at this circumstance, but the process of longitudinal clinical trials. 

Paul McGuigan, BSN, RN, CDCES


1.0 Contact Hour* Finding the GOOD in the MAD : Redeeming Patient Frustrations 
Did you know that you can’t lower an a1c?  I know...it’s a little controversial.  You see, a1c’s are lowered as a result of changed behavior.  And behaviors are driven by frustrations and victories.  How many of your patients come to their visits FULL of frustration...even mad?  These frustrations are at the root of their thoughts, actions, and ultimately the cause of many issues.  Effectively addressing them is vital to the success of the visit and overall patient health.  Learn to utilize the Frustration Index as a form of motivational interviewing to guide you through your visits and meet the patient’s needs in half the time. Getting to the root of the issue(s) leads to happier, healthier patients, lower a1c’s, and positive patient outcomes.
Jessica Adkins, DNP, CPNP-PC, BC-ADM
1.0 Contact Hour*
Happiness, Hope, and Healing

Positivity, happiness, and hope can be intentionally called upon to help navigate challenges and change.  Happiness and hope are health supportive, and the science of each have advanced.  Participants will explore the PERMA Model of happiness: Positivity, Engagement, Relationships, Meaning, & Accomplishments.   Participants will look at different types of hope.  Learners will explore personal meanings of happiness and hope, with focus on how to encourage each in ourselves and others.  A group “Hope Tree” will be created, capturing hope’s meaning to participants. Learners will self-report the importance of happiness and hope on health, personal development, and survival.  Discussion helps solidify thoughts; it can connect past experiences to current views.  

Shari Liesch, MSN, APNP
1.0 Contact Hour*
Diabetes and Language: What's in a Name?

This presentation will focus on the use of diabetes-related language in diabetes care. It will cover evidence of the impact and outcome of negative messaging, examples of negative and disengaging words, and suggestions for positive and supportive language. The presentation will also include the impact of diabetes language from a personal perspective.

Shannon Knapp, BSN, RN, CDCES
* Subject to change based upon approval 
Total number of contact hours applied for is 21.75.